WO2007053165A3 - Biopuce a proteines virales et ses utilisations - Google Patents

Biopuce a proteines virales et ses utilisations Download PDF

Info

Publication number
WO2007053165A3
WO2007053165A3 PCT/US2006/001018 US2006001018W WO2007053165A3 WO 2007053165 A3 WO2007053165 A3 WO 2007053165A3 US 2006001018 W US2006001018 W US 2006001018W WO 2007053165 A3 WO2007053165 A3 WO 2007053165A3
Authority
WO
WIPO (PCT)
Prior art keywords
protein microarray
virus protein
uses therefor
microarray
protein
Prior art date
Application number
PCT/US2006/001018
Other languages
English (en)
Other versions
WO2007053165A9 (fr
WO2007053165A2 (fr
Inventor
Heng Zhu
Mike Snyder
Jian Wang
Guozhen Liu
Shaohui Hu
Ghil Jona
Xiaowei Zhu
Original Assignee
Univ Yale
Heng Zhu
Mike Snyder
Jian Wang
Guozhen Liu
Shaohui Hu
Ghil Jona
Xiaowei Zhu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Yale, Heng Zhu, Mike Snyder, Jian Wang, Guozhen Liu, Shaohui Hu, Ghil Jona, Xiaowei Zhu filed Critical Univ Yale
Publication of WO2007053165A2 publication Critical patent/WO2007053165A2/fr
Publication of WO2007053165A9 publication Critical patent/WO2007053165A9/fr
Publication of WO2007053165A3 publication Critical patent/WO2007053165A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/165—Coronaviridae, e.g. avian infectious bronchitis virus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

L’invention concerne une biopuce à protéines virales qui constitue un outil rapide, sensible et simple pour l’identification d’anticorps spécifiques à des virus dans du sérum, par exemple une biopuce à protéines du coronavirus du SRAS. L’invention concerne également des procédés de mise en œuvre de la biopuce à protéines.
PCT/US2006/001018 2005-01-11 2006-01-11 Biopuce a proteines virales et ses utilisations WO2007053165A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US64282405P 2005-01-11 2005-01-11
US60/642,824 2005-01-11

Publications (3)

Publication Number Publication Date
WO2007053165A2 WO2007053165A2 (fr) 2007-05-10
WO2007053165A9 WO2007053165A9 (fr) 2007-07-05
WO2007053165A3 true WO2007053165A3 (fr) 2008-01-31

Family

ID=38006339

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2006/001018 WO2007053165A2 (fr) 2005-01-11 2006-01-11 Biopuce a proteines virales et ses utilisations

Country Status (1)

Country Link
WO (1) WO2007053165A2 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2023142A1 (fr) * 2007-07-30 2009-02-11 Mikrogen Molekularbiologische Entwicklungs-GmbH Dosage immunologique utilisant des protéines de capsides nucléiques recombinantes pour la détection d'anticorps aux coronavirus humains
EP3058370A4 (fr) * 2013-10-14 2017-08-30 The University of North Carolina at Chapel Hill Méthodes et compositions pour le diagnostic du coronavirus et thérapeutique
CN109734802A (zh) * 2019-03-18 2019-05-10 扬州大学 一种重组猪流行性腹泻病毒n、s蛋白单克隆抗体的制备方法
CN110273024A (zh) * 2019-05-08 2019-09-24 广西大学 基于猪流行性腹泻病毒m基因的荧光定量pcr检测引物及其试剂盒
CN111596064B (zh) * 2020-04-28 2023-03-31 江苏省农业科学院 同时检测pedv和tgev的速测卡及其制备、使用方法
CN112067712B (zh) * 2020-08-18 2022-11-01 上海纳米技术及应用国家工程研究中心有限公司 一种诊断新型冠状病毒的挥发性标志物及其应用
TWI767434B (zh) * 2020-12-01 2022-06-11 國立成功大學 蛋白質微陣列、其檢測方法、其用途及含有該蛋白質微陣列之試劑盒
US11175293B1 (en) 2021-01-04 2021-11-16 University Of Utah Research Foundation Rapid assay for detection of SARS-CoV-2 antibodies

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004096842A2 (fr) * 2003-04-28 2004-11-11 Public Health Agency Of Canada Sequences de nucleotides et d'acides amines du virus du sras, et utilisations associees
WO2005043111A2 (fr) * 2003-07-14 2005-05-12 Ciphergen Biosystems, Inc. Marqueurs biologiques seriques pour le sras

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004096842A2 (fr) * 2003-04-28 2004-11-11 Public Health Agency Of Canada Sequences de nucleotides et d'acides amines du virus du sras, et utilisations associees
WO2005043111A2 (fr) * 2003-07-14 2005-05-12 Ciphergen Biosystems, Inc. Marqueurs biologiques seriques pour le sras

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
CHEN ZELIANG ET AL: "Antigenicity analysis of different regions of the severe acute respiratory syndrome coronavirus nucleocapsid protein.", CLINICAL CHEMISTRY JUN 2004, vol. 50, no. 6, June 2004 (2004-06-01), pages 988 - 995, XP002450358, ISSN: 0009-9147 *
QIU M.F. ET AL: "Profile of Specific Antibodies to Individual Proteins of SARA-CoV and Antigenicity Analysis of Its Nucleocapsid Protein", MOLECULAR & CELLULAR PROTEOMICS, vol. 3, no. 10, October 2004 (2004-10-01), pages S273, XP002450355 *
QIU MAOFENG ET AL: "Antibody responses to individual proteins of SARS coronavirus and their neutralization activities.", MICROBES AND INFECTION / INSTITUT PASTEUR MAY 2005, vol. 7, no. 5-6, May 2005 (2005-05-01), pages 882 - 889, XP004936669, ISSN: 1286-4579 *
ZHU HENG ET AL: "Severe acute respiratory syndrome diagnostics using a coronavirus protein microarray.", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 14 MAR 2006, vol. 103, no. 11, 14 March 2006 (2006-03-14), pages 4011 - 4016, XP002450357, ISSN: 0027-8424 *

Also Published As

Publication number Publication date
WO2007053165A9 (fr) 2007-07-05
WO2007053165A2 (fr) 2007-05-10

Similar Documents

Publication Publication Date Title
WO2007053165A3 (fr) Biopuce a proteines virales et ses utilisations
IL264748B (en) Devices, methods and operators for testing
WO2005087951A3 (fr) Reactifs, procedes et kits utilise dans la desactivation d'acides nucleiques
WO2007008276A3 (fr) Sondes a renouvellement et utilisation
WO2007076132A3 (fr) Compositions comprenant des macromolecules immobilisees et orientees et leurs procedes de preparation
HK1084467A1 (en) License source component, license destination component and method thereof
EP1851238A4 (fr) Acides nucleiques d'influenza, polypeptides et leurs utilisations
AU2003216289A1 (en) Identification of peptides that facilitate uptake and cytoplasmic and/or nuclear transport of proteins, dna and viruses
WO2007044620A3 (fr) Vaccin polyvalent optimal contre le cancer
IL173843A0 (en) Assay for coronaviruses, reagents for use therein and kits containing the same
WO2005047459A3 (fr) Acides nucleiques du sars, proteines, anticorps et utilisations associees
WO2006074334A3 (fr) Identification de cibles d'arn au moyen d'helicases
WO2005100611A3 (fr) Detection d'acide nucleique viral et methode pour une transcription inverse d'arn
GB0420062D0 (en) Assay methods,materials and preparations
WO2004046314A3 (fr) Procedes de detection de dimethylarginine asymetrique dans un echantillon biologique
WO2007061969A3 (fr) Nouvelles compositions et vaccins contre les infections par les virus de la grippe a et b
WO2005013904A3 (fr) Acides nucleiques, proteines, vaccins contre le sras et leurs utilisations
IS7775A (is) DNA bóluefni sem umritar að minnsta kosti tvö óformgerð árprótín af vörtuveiru
WO2006060739A3 (fr) Essais portant sur l'ubiquitine ligase et reactifs associes
WO2006104761A3 (fr) Sondes d'hybridation unisequentielles
WO2005007893A3 (fr) Detection universelle de liaison
WO2006074157A3 (fr) Replicases pol iii modifiees et utilisations de celles-ci
WO2004091507A3 (fr) Vaccin polyvalent optimal contre le cancer
WO2004092332A3 (fr) Polypeptides de virus de sars
DE10296438D2 (de) Parameterwahlverfahren - Abstimmungsverfahren zur Parameter-Auswahl in Protokollen (z. B. TandemFreeOperation TFO)

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: RULE 160.1 EPC

122 Ep: pct application non-entry in european phase

Ref document number: 06844066

Country of ref document: EP

Kind code of ref document: A2